Human immunodeficiency virus type-1 infection in zambian children with tuberculosis: changing seroprevalance and evaluation of a thioacetazone-free regimen
- 30 April 1994
- journal article
- Published by Elsevier in Tubercle and Lung Disease
- Vol. 75 (2) , 110-115
- https://doi.org/10.1016/0962-8479(94)90039-6
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Seroprevalence of human immunodeficiency virus type 1 infection in Zambian children with tuberculosisThe Pediatric Infectious Disease Journal, 1993
- Cutaneous hypersensitivity reactions due to thiacetazone in the treatment of tuberculosis in Zambian children infected with HIV-I.Archives of Disease in Childhood, 1993
- The influence of HIV status on single and multiple drug reactions to antituberculous therapy in AfricaAIDS, 1992
- Tuberculosis in Patients with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1991
- Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosisThe Lancet, 1991
- Risk of tuberculosis in patients with HIV-I and HIV-II infections in Abidjan, Ivory Coast.BMJ, 1991
- Extrapulmonary and disseminated tuberculosis in HIV-1-seropositive patients presenting to the acute medical services in NairobiAIDS, 1990
- HIV seropositivity and tuberculosis in a rural Malawi hospitalTransactions of the Royal Society of Tropical Medicine and Hygiene, 1990
- Impact of HIV on tuberculosis in Zambia: a cross sectional study.BMJ, 1990
- The Association of Tuberculosis and HIV Infection in BurundiAIDS Research and Human Retroviruses, 1989